Leaflet NINTEDANIB DR REDDY'S 150mg soft capsules
Indicated for: cancer
Route of administration: oral
Substance: nintedanib (antineoplastic agent)
ATC: L01EX09 (Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Nintedanib is a medication used for the treatment of idiopathic pulmonary fibrosis and other progressive interstitial lung diseases. It is a tyrosine kinase inhibitor that works by reducing inflammation and fibrosis in the lungs.
The medication is taken orally, usually twice daily with meals. The dose is adjusted based on the patient's tolerance and any adverse reactions. Common side effects include diarrhea, nausea, vomiting, and decreased appetite.
Nintedanib is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with severe liver impairment.
This medication is an important option for patients with progressive lung diseases, helping to slow disease progression and improve their quality of life.
General data about NINTEDANIB DR REDDY'S 150mg
- Substance: nintedanib
- Date of latest medicines list: 01-06-2026
- Product code: W71296002
- Concentration: 150mg
- Pharmaceutical form: soft capsules
- Quantity: 60
- Product type: Generic medicine
- Price: 6727.07 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for nintedanib
- 100mg
- 150mg
- 25mg
Compensation lists for NINTEDANIB DR REDDY'S 150mg Dr. Reddy's
NHP 6.20 (C2) - Idiopathic pulmonary fibrosis
Price
Copayment
Patient
6727.07 RON
4257.24 RON
2469.83 RON